A CROSS-SECTIONAL STUDY OF SILENT MYOCARDIAL INFARCTION AMONG TYPE 2 DIABETICS.

Autor: Prashant Kumar, Akhilesh Kumar, Rahul Raj

Publikováno v: Student's Journal of Health Research Africa, Vol 4, Iss 12 (2023)

Introduction: Diabetes mellitus type 2 typically affects adults when the body doesn't produce enough insulin or grows resistant to it, leading to several micro- and macrovascular. This study used an activity treadmill test to assess the severity of

Externí odkaz: https://doaj.org/article/034de036b3554e7790faaede4e31a217

Silent Myocardial Ischemia: From Pathophysiology to Diagnosis and Treatment

Autor: Panagiotis Theofilis, Alexios S. Antonopoulos, Marios Sagris, Aggelos Papanikolaou, Evangelos Oikonomou, Konstantinos Tsioufis, Dimitris Tousoulis

Publikováno v: Biomedicines, Vol 12, Iss 2, p 259 (2024)

Silent myocardial ischemia (SMI), characterized by a lack of overt symptoms despite an inadequate blood supply to the myocardium, remains a challenging entity in cardiovascular medicine. The pathogenesis involves intricate interactions of vascular, n

Externí odkaz: https://doaj.org/article/582146de26b64873a19b83321776078c

Burden of arrhythmia and silent ischemia in heart transplant patients with cardiac allograft vasculopathy

Autor: Kamillla Pernille Bjerre, Henning Mølgaard, Steen Hvitfeldt Poulsen, Hans Eiskjær, Katrine Berg, Brian Bridal Løgstrup, Tor Skibsted Clemmensen

Publikováno v: Berg, K, Bjerre, K P, Clemmensen, T S, Løgstrup, B B, Mølgaard, H, Poulsen, S H & Eiskjær, H 2021, ' Burden of arrhythmia and silent ischemia in heart transplant patients with cardiac allograft vasculopathy ', Scandinavian Cardiovascular Journal, vol. 55, no. 5, pp. 300-307 . https://doi.org/10.1080/14017431.2021.1955961

BACKGROUND: The incidence of sudden cardiac death (SCD) following heart transplantation (HTx) accounts for approximately 10% of post-HTx deaths. Ischemia, brady- and tachy-arrhythmias caused by rejection and cardiac allograft vasculopathy (CAV) seem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d2f0092af8502a8656537fd70b58457c
https://doi.org/10.1080/14017431.2021.1955961

Influence of a complex tratment on serum lipid profile and clinical course of ischemic heart disease inworkers of mining industry

Autor: Fesenko V.I., Роtabashniy V.A.

Publikováno v: Medičnì Perspektivi, Vol 21, Iss 1, Pp 46-51 (2016)

The aim of our study was to investigate the effectiveness of combined therapy with antiplatelet agent clopidogrel (Plagril®, “Dr. Reddy’s Laboratories Limited”, India), and lipid-lowering agent atorvastatin (Atocor®, “Dr. Reddy’s Laborato

Externí odkaz: https://doaj.org/article/ff0b1458a00241248f3b17032413e37d

CLINICAL AND FUNCTIONAL CHARACTERISTICS OF PATIENTS AFTER Q-WAVE MYOCARDIAL INFARCTION DEPENDING ON THE METABOLIC SYNDROME PRESENCE OR ABSENCE

Autor: R. D. Kurbanov, N. U. Zakirov, N. B. Sayfiddinova, G. U. Mullabaeva, G. A. Nagaeva, Yu. G. Kevorkova

Publikováno v: Рациональная фармакотерапия в кардиологии, Vol 9, Iss 5, Pp 488-493 (2015)

Aim. To study the clinical and functional parameters of patients after acute Q-wave myocardial infarction (Q-MI) depending on the concomitant metabolic syndrome (MS). Material and methods. Men after Q-MI (n=79; aged 51.7±8.9 years) were included int

Externí odkaz: https://doaj.org/article/ade29886a23d4a1484cf32c2dbf89e98